{"SPADE_N_00056": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_00056", "Peptide Name": "Aureocin A53 (Bacteriocin)", "Source": "Staphylococcus aureus A53 (Gram-positive bacteria)", "Family": "Belongs to the class II bacteriocin", "Gene": "aucA", "Sequence": "MSWLNFLKYIAKYGKKAVSAAWKYKGKVLEWLNVGPTLEWVWQKLKKIAGL", "Sequence Length": 51, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q8GPI4"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive bacteria:Listeria monocytogenes, Staphylococcus simulans (MIC=100 nM), Staphylococcus aureus (MRSA), Streptococcus agalactiae, Micrococcus luteus (MIC=0.15 nM).", "Hemolytic Activity": "[Ref.12054867] No hemolytic activity was detected when purified aureocin A53 was spotted on sheep blood agar plates (data not shown in the reference).", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Cell membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Formylation", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C291H447N69O65S", "Mass": 5984.15, "PI": 10.07, "Net Charge": 8, "Hydrophobicity": -0.08, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Function": "Antibacterial peptide. It causes membrane permeation.", "Literature": [{"Title": "Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.", "Pubmed ID": "12054867", "Reference": "J Mol Biol. 2002 Jun 7;319(3)745-756.", "Author": "Netz DJ, Pohl R, Beck-Sickinger AG, Selmer T, Pierik AJ, Bastos Mdo C, Sahl HG.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12054867"}], "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDHORU", "Basic Residues": 10, "Acidic Residues": 2, "Hydrophobic Residues": 29, "Polar Residues": 28, "Positive Residues": 10, "Negative Residues": 2, "Similar Sequences": []}}}